VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6539AA: VAERS reports

25 VAERS reports list lot U6539AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2019-11-19 and 2022-05-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2632%
Neurological1518%
General / Systemic (non-local)911%
Allergic / Anaphylactic810%
Musculoskeletal79%
Cardiac / Cardiovascular56%
Gastrointestinal56%
Dermatological (non-injection-site)56%
Respiratory22%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York3
Pennsylvania3
Florida3
North Carolina2
Arizona2
Virginia1
Georgia1
Nebraska1
Texas1
Oregon1
Tennessee1
Minnesota1

Reports by month received

2019-111
2019-124
2020-012
2020-023
2020-032
2020-041
2020-051
2020-071
2020-085
2020-092
2020-121
2021-081
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.